Jeffrey Moses, MD
Interventional Cardiology · New York, NYNPI 1447369368
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (36.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Abiomed at 45.4% of the total. Reporting peaked in 2019 at $61,949 and has fallen 79.9% since, to $12,465 in 2025. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 647 payments — averaging $368.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$108K
- Boston Scientific$51K
- Philips North America LLC$28K
- Siemens Medical Solutions USA, Inc.$10K
- Medtronic$10K
- Verge Medical, Inc.$9K
- plus $22K from 28 others
Across 123 payments — averaging $5780.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$473K
- Abbott$144K
- Shockwave Medical, Inc$75K
- Medtronic$18K
- Abiomed$319
What the payments were for
- Consulting fees$43,80018%
- Speaking & faculty fees$85,96836%
- Travel & lodging$58,76125%
- Food & beverage$37,27016%
- Entertainment$1820%
- Ownership interest$12,4975%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 97 | $108,181 |
| Boston Scientific | 111 | $50,707 |
| Philips North America LLC | 30 | $28,442 |
| Siemens Medical Solutions USA, Inc. | 36 | $10,350 |
| Medtronic(2 entities) | 110 | $10,242 |
| Verge Medical, Inc. | 1 | $8,500 |
| Cardiovascular Systems Inc. | 24 | $6,203 |
| Abbott | 142 | $5,252 |
| Shockwave Medical, Inc | 9 | $2,847 |
| Edwards Lifesciences | 21 | $2,433 |
| Teleflex LLC | 6 | $710 |
| Cathworks, Inc. | 3 | $590 |
| Opsens Inc. | 4 | $503 |
| GE HealthCare | 4 | $482 |
| Biotronik Inc. | 6 | $310 |
| Recor Medical Inc | 4 | $303 |
| Asahi Intecc USA, Inc. | 4 | $302 |
| Spectrawave, Inc | 2 | $286 |
| ZOLL Circulation Inc | 1 | $239 |
| W. L. Gore & Associates, Inc. | 4 | $229 |
| AstraZeneca | 4 | $196 |
| Myocardial Solutions, Inc. | 1 | $173 |
| Heartflow, Inc. | 2 | $168 |
| Boehringer Ingelheim | 8 | $154 |
| Ancora Heart, Inc. | 1 | $146 |
| Cardiva Medical, Inc. | 2 | $135 |
| Johnson & Johnson | 1 | $124 |
| Arrow International, Inc. | 2 | $96 |
| Angiodynamics, Inc. | 1 | $47 |
| Amgen | 2 | $40 |
| Bridgebio Pharma, Inc. | 1 | $27 |
| Cordis US CORP. | 1 | $21 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$106,237
- (9520) IGT Devices Undivided$27,701
- GENERAL - THERAPIES$20,549
- GENERAL VASCULAR ACCESS$13,313
- FLASH Ostial System$8,500
- FLASH Mini Ostial System$8,500
- ROTABLATOR$6,604
- CROSSBOSS$4,000
- Coronary Orbital Atherectomy System$3,520
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$2,512
- Diamondback Coronary$2,284
- Resolute$2,130
- ONYX FRONTIER$1,913
- CoreValve Evolut$1,893
- AVVIGO Guidance System$1,531
- Artis icono floor$1,077
- RESOLUTE ONYX$1,009
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$957
- Xience V coronary stent system$856
- OPTIS$757
How this compares
$238,477 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 11 | $281 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in New York
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- Prakash KrishnanNew York$387K
- Jaikirshan KhatriNew York$307K
- Samin SharmaNew York$291K
- Torsten VahlNew York$280K
- George DangasNew York$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.